Statistics in Medicine

Article	Citations
	386
	134
	96
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies	95
Incorporating survival data into case‐control studies with incident and prevalent cases	62
Robustness of κ‐type coefficients for clinical agreement	54
Transportability of model‐based estimands in evidence synthesis	52
A simulation study of disaggregation regression for spatial disease mapping	48
	44
On the parameter estimation of Box‐Cox transformation cure model	44
	43
Optimal confidence intervals for the relative risk and odds ratio	40
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures	40
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model	40
Real time monitoring and prediction of time to endpoint maturation in clinical trials	36
Estimands for factorial trials	35
Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm	34
Synthesizing studies for comparing different treatment sequences in clinical trials	33
Network and covariate adjusted response‐adaptive design for binary response	31
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	31
Bayesian mixture modelling with ranked set samples	30
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model	29
Improving main analysis by borrowing information from auxiliary data	26
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	25
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	24

Data fusion for predicting long‐term program impacts	24
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	24
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule	22
The polytomous discrimination index for prediction involving multistate processes under intermittent observation	22
Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models	22
Bayesian additive regression trees for multivariate skewed responses	21
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints	20
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	20
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	20
The Whys, Whens, and Hows of Futility Monitoring	19
Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology	19
Issue Information	18
Issue Information	18
Issue Information	18
Correction to “A Comparison of Methods to Adjust Survival Curves for Confounders”	17
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	17
Regression Trees With Fused Leaves	16
Dynamic Single‐Index Scalar‐On‐Function Model	16
Confidence Intervals for AUC and pAUC by Empirical Likelihood	16
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries	16
Bayesian model‐averaged meta‐analysis in medicine	16
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	15
Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias	15
Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states	15
Finding the best subgroup with differential treatment effect with multiple outcomes	14
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure	14
Estimating contact network properties by integrating multiple data sources associated with infectious diseases	14
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults	14
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data	14
Multiple multi‐sample testing under arbitrary covariance dependency	14
Sensitivity analysis of G‐estimators to invalid instrumental variables	14
Instrumental variable model average with applications in Mendelian randomization	14
A multivariate statistical approach to predict COVID‐19 count data with epidemiological interpretation and uncertainty quantification	13
Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome	13
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine	13
Information‐incorporated sparse hierarchical cancer heterogeneity analysis	13
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system	13
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model	13
Modeling intra‐individual inter‐trial EEG response variability in autism	13
Nonparametric empirical Bayes biomarker imputation and estimation	13
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	13
IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication	12
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	12
Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects	12
Multilevel Longitudinal Functional Principal Component Model	12
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments	12
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome	12
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart	12
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies	12
A systematic review and evaluation of statistical methods for group variable selection	12

Covariate adjustment in randomized clinical trials with missing covariate and outcome data	12
Issue Information	11
Optimal adaptive allocation using deep reinforcement learning in a dose‐response study	11
	11
Standardization and other approaches to meta‐analyze differences in means	11
Relative sparsity for medical decision problems	11
Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score	11
Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment	11
Outlier Detection in Mendelian Randomization	11
	11
	11
A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine	11
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight	11
	11
	11
Group sequential designs for clinical trials when the maximum sample size is uncertain	10
Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules	10
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data	10
Modeling conditional reference regions: Application to glycemic markers	10
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation	10
Handling missing within‐study correlations in the evaluation of surrogate endpoints	10
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial	10
Local false discovery rate estimation with competition‐based procedures for variable selection	10
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions	10
Joint regression modelling of intensity and timing of accelerometer counts	10
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis	10
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity	10
Leveraging real‐world evidence for determining performance goals for medical device studies	10
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome	10
Obituary: Anthony Leonard Johnson (1943‐2022)	10
Flexible template matching for observational study design	9
Correction to “Using principal stratification in analysis of clinical trials”	9
Subgroup Testing in the Change‐Plane Cox Model	9
New methods for multiple testing in permutation inference for the general linear model	9
Complex survival trial design by the product integration method	9
Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates	9
Propensity score analysis with local balance	9
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome	9
Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067	9
Robust inference for causal mediation analysis of recurrent event data	9
Flexible propensity score estimation strategies for clustered data in observational studies	9
Structured time‐dependent inverse regression (STIR)	9
	9
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model	9
Association analysis of self‐reported outcomes with a validated subset	9
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making	9
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations	9
	8
	8
Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy	8
Optimal weighted Bonferroni tests and their graphical extensions	8
Bland–Altman Plot for Censored Variables	8
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows	8
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures	8
	8
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data	8
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing	8
	8
Issue Information	8
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals	8
Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment	8
Transfer Learning for Error‐Contaminated Poisson Regression Models	8
Peter Armitage speaking on the occasion of the 50th Anniversary of the M.Sc. in Medical Statistics, LSHTM (for the Symposium on April 11‐12, 2019)	8
Multi‐threshold proportional hazards model and subgroup identification	8
Causal inference methods for vaccine sieve analysis with effect modification	8
	8
Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression model	8
Issue Information	8
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation	8
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies	8
Issue Information	8
A function‐based approach to model the measurement error in wearable devices	8
Mixed‐type multivariate response regression with covariance estimation	7
Issue Information	7
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards	7
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model	7
Sample size determination for prediction models via learning‐type curves	7
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies	7
Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding	7
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths	7

Weighted generalized estimating equations and unified estimation for longitudinal data with nonmonotone missing data patterns	7
Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)	7
Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake	7
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints	7
Issue Information	7
Issue Information	7
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data	7
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection	7
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints	7
Confidence intervals for odds ratio from multistage randomized phase II trials	7
A sequential, multiple assignment, randomized trial design with a tailoring function	7
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition	7
Robust structured heterogeneity analysis approach for high‐dimensional data	7
Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure	7
Issue Information	7
Issue Information	7
Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies	7
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases	7
A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies	7
Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration	7
A classification for complex imbalanced data in disease screening and early diagnosis	7
Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures	7
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time	7
Minimization in randomized clinical trials	7
Properties of the full random‐effect modeling approach with missing covariate data	6
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data	6
Set‐regression with applications to subgroup analysis	6
Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity	6
Measurement errors in control risk regression: A comparison of correction techniques	6
	6
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference	6
Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships	6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks	6
Issue Information	6
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data	6
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease	6
	6
A Simple Diagnostic for the Positivity Assumption for Continuous Exposures	6
An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis	6
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression	6
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models	6
Allocation in platform trials to maintain comparability across time and eligibility	6
Robust inference methods for meta‐analysis involving influential outlying studies	6
Fast estimation of mixed‐effects location‐scale regression models	6
Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors	6
Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices	6
Unified semicompeting risks analysis of hepatitis natural history through mediation modeling	6
Joint modeling approaches for censored predictors due to detection limits with applications to metabolites data	6
Assessing heterogeneity in surrogacy using censored data	6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables	6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method	6
Penalized maximum likelihood inference under the mixture cure model in sparse data	6
Radiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis	6
Robust analysis of cancer heterogeneity for high‐dimensional data	6
A conditional autoregressive model for genetic association analysis accounting for genetic heterogeneity	6
	6
A penalization approach to random‐effects meta‐analysis	6
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications	6
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial	6
Optimal diagnostic test allocation strategy during the COVID‐19 pandemic and beyond	6
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs	6
Integrative deep learning with prior assisted feature selection	6
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation	6
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials	6
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic	6
A Novel Bayesian Spatio‐Temporal Surveillance Metric to Predict Emerging Infectious Disease Areas of High Disease Risk	6
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes	6
Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data	6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging	6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo	6
Fitting additive risk models using auxiliary information	6
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data	6
A Note on the Sample Size Formula for a Win Ratio Endpoint	6
A comparison of different methods to adjust survival curves for confounders	6
Federated causal inference in heterogeneous observational data	6
	6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial	6
Correlated geometric models of order k and its application to intensive care unit and leprosy data	6
Individualized empirical null estimation for exact tests of healthcare quality	5
A semi‐parametric Bayesian model for semi‐continuous longitudinal data	5
Nonparametric estimation of marked survival data in the presence of dependent censoring	5
Overall assessment for selected markers from high‐throughput data	5
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit	5
A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint	5
Bayesian federated inference for estimating statistical models based on non‐shared multicenter data sets	5
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis	5
Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities	5
Cluster randomized trial designs for modeling time‐varying intervention effects	5
Exact test and exact confidence interval for the Cox model	5
Point estimation for adaptive trial designs II: Practical considerations and guidance	5
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study	5
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials	5
Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model	5
A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications	5
Bayesian hierarchical models for high‐dimensional mediation analysis with coordinated selection of correlated mediators	5